Tuberculosis research, Experimental antibiotics, Drug-resistant TB, Mycobacterium tuberculosis, ClpC1 ClpP1P2, Antibiotic resistance, Infectious disease research, TB drug development, Proteomics, Antimicrobial therapy, experimental antibiotics for tuberculosis, drug-resistant TB, Mycobacterium tuberculosis, ClpC1 ClpP1P2 complex, tuberculosis treatment research, new TB drugs, antibiotic resistance, TB protein degradation, ecumicin ilamycin cyclomarin, infectious disease research, TB drug targets, antimicrobial research, tuberculosis bacteria, TB clinical research, global TB burden
Tuberculosis Breakthrough with Experimental Antibiotics

Key Takeaways Experimental antibiotics disrupt a vital protein degradation system in Mycobacterium tuberculosis Findings explain.

Healthy Longevity, VITAL-H Trial, ARPA-H Funding, Aging Research, Healthspan, Intrinsic Capacity, Geriatric Medicine, Preventive Care, FDA-Approved Drugs, Clinical Trials, healthy longevity clinical trial, aging research funding, ARPA-H PROSPR program, VITAL-H study, healthspan interventions, intrinsic capacity aging, FDA-approved drugs aging, rapamycin longevity, semaglutide aging, dapagliflozin healthspan, geriatric clinical trials, preventive aging medicine, wearable health monitoring, midlife aging study, longevity science
National Healthy Longevity Trial Receives Federal Support

Key Summary Up to $38 million in federal funding awarded to the Barshop Institute at.

Red blood cells, glucose metabolism, hypoxia, diabetes research, erythrocytosis, glucose tolerance, insulin independent, high altitude physiology, metabolic research, red blood cells glucose metabolism, hypoxia and diabetes, glucose tolerance, erythrocytosis, insulin independent glucose uptake, GLUT1 GLUT4, high altitude hypoxia, diabetes biology, metabolic adaptation, RBC metabolism, glycolysis, Luebering Rapoport shunt, hypoxic adaptation, fasting glucose, translational diabetes research
Red Blood Cells Improve Glucose Tolerance Under Hypoxia

Key Takeaways for Clinicians Chronic hypoxia lowers fasting glucose and improves glucose tolerance independent of.

Nanoplastics, Brain Health, Neurodegenerative Diseases, Neuroinflammation, Environmental Exposure, Plastic Pollution, Neurology Research, Public Health, nanoplastics in brain tissue, neurodegenerative disease, neuroinflammation, plastic exposure, protein aggregation, Alzheimer’s disease, Parkinson’s disease, blood brain barrier, environmental plastics, neurological disorders, nanoplastic exposure, brain health research, plastic pollution health, clinical neuroscience, public health risk
Nanoplastics in Brain Tissue and Neurological Risk

Key Takeaways for HCPs Nanoplastics are now detected in human brain tissue and blood Evidence.

Chronic GVHD, Stem Cell Transplant, Bone Marrow Transplant, AI in Transplant Medicine, Immune Biomarkers, Transplant Complications, Precision Medicine, Hematology, Oncology Research, Clinical Decision Support, transplant mortality risk, machine learning medicine, GVHD prediction, post-transplant care, precision transplant medicine, hematology oncology, clinical risk models, transplant immunology, BIOPREVENT
AI Predicts Chronic GVHD Risk After Stem Cell Transplant

Key Takeaways A new AI-driven tool, BIOPREVENT, predicts chronic GVHD and transplant-related mortality before symptoms.

Red Meat Intake, Diabetes, Red Meat Consumption, Nutrition research, NHANES, Metabolic health, Plant-based protein, Processed meat, Public health nutrition, Type 2 diabetes, Dietary patterns, processed red meat risk, unprocessed red meat diabetes, NHANES diabetes study, plant-based protein diabetes, dietary substitution diabetes, protein sources metabolic health, diabetes prevalence US adults, nutrition and diabetes risk, dietary patterns diabetes, public health nutrition, diabetes prevention diet, metabolic disease research, clinical nutrition, population health study
Red Meat Consumption Linked to Higher Diabetes Odds

Key Takeaways Higher intake of total, processed, and unprocessed red meat is associated with greater.

Pediatric Crohn’s Disease, Gut microbiome, Inflammatory bowel disease, IBD research, Fecal microbiome profiling, PCDAI, Pediatric gastroenterology, Microbial biomarkers, Gut dysbiosis, Pro-inflammatory bacteria, Firmicutes, Proteobacteria, NYU research, IBS vs Crohn’s, Personalized medicine, Crohn’s disease severity index, pro-inflammatory bacteria, Proteobacteria in Crohn’s, Firmicutes depletion, microbiome diversity, pediatric gastroenterology, microbiome-targeted therapy
Pediatric Crohn’s Disease Microbial Signature Identified

Key Points at a Glance NYU researchers identified a distinct microbial signature in pediatric Crohn’s.

Nanovaccine, Nanovaccine design, HPV tumors, Structural nanomedicine, Spherical nucleic acids, Cancer immunotherapy, CD8 T cells, Head and neck cancer, Cervical cancer, Oncology research, Therapeutic cancer vaccine, Interferon gamma, Tumor immunology, Nanotechnology in medicine, Science Advances study, Translational oncology
Nanovaccine Design Boosts Immune Attack on HPV Tumors

Key Highlights Reconfiguring peptide orientation significantly strengthened the CD8+ T cell response. Surface-displayed antigen (N-terminus.

High-fat diets, metabolic health, ketogenic diet liver damage, high-carbohydrate diet, liver inflammation, glucose intolerance, saturated fat health risks, whole-grain diet benefits, fiber supplementation keto, obesity research, Journal of Nutrition study, diet and liver function, triglycerides and heart risk, dietary fat vs carbohydrates, Penn State nutrition research, Journal of Nutrition study, dietary fat vs carbohydrates, liver scarring inflammation genes, refined carbohydrates metabolic impact
High-Fat Diets Cause Damage to Metabolic Health

Key Points Takeaways High-fat and ketogenic diets led to greater weight gain, liver injury, and.

Acute Ischemic Stroke, Neuroprotective Drugs, Loberamisal, Stroke Recovery, Phase III Clinical Trial, Neuroprotection, NIHSS, Modified Rankin Scale, Stroke Research, International Stroke Conference, American Stroke Association, IV Stroke Therapy, Brain Health, HCP Education, NIHSS score, modified Rankin Scale, stroke clinical trial, brain cell protection, intravenous stroke therapy, stroke outcomes, American Stroke Association, International Stroke Conference
Acute Ischemic Stroke: New Evidence for Neuroprotection

Key Highlights A Phase III clinical trial presented at the International Stroke Conference 2026 reports.